Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Reappraisal of the genetic diversity and pharmacogenetic assessment of CES1

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics

    Research output: Contribution to journalReviewResearchpeer-review

  3. The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Novel Genetic Causes of Gastrointestinal Polyposis Syndromes

    Research output: Contribution to journalReviewResearchpeer-review

  3. Challenges in conducting paediatric trials with off-patent drugs

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The CES1 gene encodes a hydrolase that metabolizes important drugs. Variants generated by exchange of segments with CES1P1 complicate genotyping of CES1. Using a highly specific procedure we examined DNA samples from 200 Caucasians and identified 46 single nucleotide variants (SNVs) in CES1 and 21 SNVs in CES1A2, a hybrid composed of CES1 and CES1P1. Several of these SNVs were novel. The frequencies of SNVs with a potential functional impact were below 0.02 suggesting limited pharmacogenetic potential for CES1 genotyping. In silico PCR revealed that the majority of the primer pairs for amplification of CES1 or CES1A2 in three previous studies lacked specificity, which partially explains a limited overlap with our findings.

Original languageEnglish
JournalPharmacogenomics
Volume18
Issue number13
Pages (from-to)1241-1257
Number of pages17
ISSN1462-2416
DOIs
Publication statusPublished - Aug 2017

    Research areas

  • Journal Article

ID: 51638560